$ Value
$13K
Shares
69
Price
$184
Filed
Feb 20
Insider
Name
SAMAD SAM
Title
Executive Vice President & CFO
CIK
0001694295
Roles
Transaction Details
Transaction Date
2026-01-28
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,910
Footnotes
Represents an award of restricted stock units. | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. | Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Filing Info
SAMAD SAM's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | DGX | F | $178K |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-18 | DGX | F | $180K |
| 2026-02-18 | DGX | F | $209K |
| 2026-02-18 | DGX | A | $0 |
| 2026-01-28 | DGX | A | $13K |
| 2025-10-21 | DGX | A | $13K |
| 2025-07-21 | DGX | L | $12K |
| 2025-07-16 | DGX | F | $144K |
| 2025-05-07 | IDXX | A | $0 |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $337K | 2026-03-03 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $1.4M | 2026-03-03 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-02 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |